1-6 of 6
Cecilie Hveding Blimark
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Risk of Infections in Multiple Myeloma in the Era of Novel Agents, a Population-Based Study Based on 8672 Multiple Myeloma Patients Diagnosed 2008-2021 from the Swedish Myeloma Registry

Cecilie Hveding Blimark, Kristina Carlson, Christopher Day, Sigrun Einarsdottir, Gunnar Juliusson, Moshtak Karma, Dorota Knut-Bojanowska, Gunnar Larfors, Ingemar Turesson, Mariana Villegas Scivetti, Ingigerdur Sverrisdottir
Journal: Blood
Blood (2023) 142 (Supplement 1): 4696.
https://doi.org/10.1182/blood-2023-174228
Published: 2023
Journal Articles

Income and Education Affect Prognosis and Treatment in Symptomatic Myeloma: A Population-Based Study on 8672 Multiple Myeloma Patients Diagnosed 2008-2021 from the Swedish Myeloma Registry

Gunnar Larfors, Kristina Elisabet Carlson, Christopher Day, Sigrun Einarsdottir, Gunnar Juliusson, Moshtak Karma, Dorota Knut-Bojanowska, Ingigerdur Sverrisdottir, Ingemar Turesson, Mariana Villegas Scivetti, Cecilie Hveding Blimark
Journal: Blood
Blood (2023) 142 (Supplement 1): 4723.
https://doi.org/10.1182/blood-2023-180637
Published: 2023
Journal Articles

Vaccine-Preventable Infections in Multiple Myeloma: A Population-Based Study on 8672 Myeloma Patients Diagnosed 2008-2021 from the Swedish Myeloma Registry

Sigrun Einarsdottir, Ingigerdur Sverrisdottir, Mariana Villegas Scivetti, Christopher Day, Ingemar Turesson, Gunnar Juliusson, Kristina Elisabet Carlson, Gunnar Larfors, Cecilie Hveding Blimark
Journal: Blood
Blood (2023) 142 (Supplement 1): 4704.
https://doi.org/10.1182/blood-2023-184444
Published: 2023
Journal Articles

Upfront Autologous Stem Cell Transplantation in Myeloma Patients >65 Years: A Population-Based Study from the Nordic Myeloma Study Group

Kari Lenita Falck Moore, Anna Genell, Ain Kaare, Dorota Knut-Bojanowska, Diana Loigom, Anna Lysen, Jakob Nordberg Nørgaard, Katrin Palk, Maris Pärnat, Valdas Peceliunas, Sæmundur Rögnvaldsson, Fredrik Schjesvold, Alexander Sigurdsson, Agoston Gyula Szabo, Jonathan Thorsen, Sigrun Thorsteinsdottir, Vilmantė Vaitekėnaitė, Annette J. Vangsted, Cecilie Hveding Blimark
Journal: Blood
Blood (2023) 142 (Supplement 1): 4729.
https://doi.org/10.1182/blood-2023-172546
Published: 2023
Journal Articles

Modified Delphi Method Identifies Consensus Areas for Routine Minimal Residual Disease Testing in Multiple Myeloma

Karthik Ramasamy, Hervé Avet-Loiseau, Cecilie Hveding Blimark, Michel Delforge, Francesca Gay, Salomon Manier, Joaquin Martinez-Lopez, Maria-Victoria Mateos, Mohamad Mohty, Niels W.C.J. van de Donk, Katja Weisel
Journal: Blood
Blood (2021) 138 (Supplement 1): 1631.
https://doi.org/10.1182/blood-2021-144578
Published: 2021
Journal Articles

A Randomized Phase 2 Trial Comparing Carfilzomib-Dexamethasone Vs Observation As Maintenance after Induction with Carfilzomib-Cyclophosphamide-Dexamethasone in Salvage ASCT in Multiple Myeloma: A Trial By the Nordic Myeloma Study Group

Henrik Gregersen, MD PhD, Valdas Peceliunas, MD, Kari Remes, MD PhD, Fredrik H. Schjesvold, MD PhD, Niels Abildgaard, MD, Hareth Nahi, MD PhD, Niels Frost Andersen, MD PhD, Annette Juul Vangsted, MD PhD, Tobias Wirenfeldt Klausen, M.S., Carsten Helleberg, MD, Kristina Carlson, MD, Ulf Christian Frølund, MD, Per Axelsson, MD, Olga Stromberg, MD, Cecilie Hveding Blimark, PhD MD, Olle Linder, MD, Galina Tsykunova, MD, Anders Waage, MD PhD, Markus Hansson, MD PhD, Nina Gulbrandsen
Journal: Blood
Blood (2019) 134 (Supplement_1): 601.
https://doi.org/10.1182/blood-2019-122141
Published: 2019